Immitra Bio vs IMU Biosciences

Immitra Bio vs IMU Biosciences, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immitra Bio is on 48/100 and IMU Biosciences on 47/100.

Immitra Bio logo
Immitra BioScalable, one-time curative in-vivo gene editing therapies.
Try Immitra Bio
IMU Biosciences logo
IMU BiosciencesDecoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.
Try IMU Biosciences

Where each one leads

Immitra Bio

Leads on none of the measures we hold for both companies.

IMU Biosciences

  • agent readiness: 42/100 against 29/100
  • domain rating: 23/100 against 8/100
  • funding raised: $53.0M against $2.6M

At a glance

MeasureImmitra BioIMU Biosciences
What it isScalable, one-time curative in-vivo gene editing therapies.Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.
CategoryBiotechnology, Gene Therapy, Genetics, HealthcareBiotechnology, Artificial Intelligence, HealthTech, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded2024Not published
HeadquartersZürich, SwitzerlandLondon, United Kingdom
StatusActiveActive

Size, funding and growth

MeasureImmitra BioIMU Biosciences
Total funding$2.6M$53.0M
Latest roundPre-SeedSeries A
LinkedIn followers2,336Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImmitra BioIMU Biosciences
StartupHub scoreOur 0-100 rating48/10047/100
Traction32/10039/100
Team70/100Not published
Search visibility33/1004/100
Quality52/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (29/100)D (42/100)
Domain ratingLink authority, 0-1008/10023/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImmitra BioIMU Biosciences
CDNFastlyNot detected
CMSNot detectedFramer
FrameworksBootstrapNot detected

Immitra Bio vs IMU Biosciences: common questions

Which is better, Immitra Bio or IMU Biosciences?

On our 0-100 score Immitra Bio rates higher (48/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.

How do Immitra Bio and IMU Biosciences compare on the numbers?

IMU Biosciences leads on agent readiness (42/100 against 29/100), domain rating (23/100 against 8/100), funding raised ($53.0M against $2.6M).

Read the full Immitra Bio review and pricing or the IMU Biosciences review and pricing. You can also browse other Immitra Bio alternatives we track.